Figure 2. Plots of duration of time on therapy and response for each patient. (A) Obinutuzumab plus B. (B) Obinutuzumab plus FC. Allo SCT, allogeneic stem cell transplantation; FCR, fludarabine and cyclophosphamide plus rituximab.
Figure 2

Plots of duration of time on therapy and response for each patient. (A) Obinutuzumab plus B. (B) Obinutuzumab plus FC. Allo SCT, allogeneic stem cell transplantation; FCR, fludarabine and cyclophosphamide plus rituximab.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal